Facet Biotech Sold
Published on March 10, 2010 by
Facet Biotech Sold – Drug and medical products company Abbott Laboratories said Tuesday it will buy Facet Biotech Corp. for about $450 million in cash, expanding the company’s access to biotechnology drugs, including a potential treatment for multiple sclerosis. Facet and its partner Biogen Idec plan to move the potential multiple sclerosis drug daclizumab into [...]
Tags: Abbott Laboratories, Biogen, Biogen Idec, Biotechnology Drugs, Boards Of Directors, Cancer Treatments, Cash And Marketable Securities, Centerview Partners, Chicago Ill, Daclizumab, Facet, Financial Adviser, Medical Products Company, Multiple Sclerosis, North Chicago, Redwood City Calif, Sclerosis Drug, Stage Development, Stages Of Development, Time Charge
Posted in Money
No Comments